Demetra acquires Maxxspine Innovative GmbH
Analysis based on 6 articles · First reported Apr 30, 2026 · Last updated Apr 30, 2026
The acquisition of Maxxspine Innovative GmbH by Demeter is expected to positively impact Demeter's market position in spine surgery, particularly in European markets, by expanding its portfolio and strengthening its presence. This move could lead to increased competition and innovation within the medical devices industry, potentially affecting other players in the orthopedic and spinal solutions sector.
Demeter, an international medical company specializing in orthopedic, spine, and neuro applications, has successfully acquired Maxxspine Innovative GmbH, a German company focused on advanced spinal surgery solutions. The acquisition was completed through Demeter's subsidiary, Osartis GmbH, which now holds 100% ownership and control of Maxxspine Innovative GmbH. This strategic move aims to strengthen Demeter's presence in key European spine surgery markets and expand its product portfolio, particularly in kyphoplasty. Both Michele Perrino, CEO of Demeter, and Volker Ludwig, CEO of Maxxspine Innovation, expressed positive outlooks on the integration, anticipating enhanced capabilities and growth opportunities for the combined entity.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard